U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C12H14N4O3
Molecular Weight 262.2646
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 3-DEAZANEPLANOCIN

SMILES

NC1=NC=CC2=C1N=CN2[C@@H]3C=C(CO)[C@@H](O)[C@H]3O

InChI

InChIKey=OMKHWTRUYNAGFG-IEBDPFPHSA-N
InChI=1S/C12H14N4O3/c13-12-9-7(1-2-14-12)16(5-15-9)8-3-6(4-17)10(18)11(8)19/h1-3,5,8,10-11,17-19H,4H2,(H2,13,14)/t8-,10-,11+/m1/s1

HIDE SMILES / InChI

Molecular Formula C12H14N4O3
Molecular Weight 262.2646
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
Broad-spectrum antiviral activities of neplanocin A, 3-deazaneplanocin A, and their 5'-nor derivatives.
1989 Aug
Synthesis of 3-deazaneplanocin A, a powerful inhibitor of S-adenosylhomocysteine hydrolase with potent and selective in vitro and in vivo antiviral activities.
1989 Jul
Inhibitory activity of S-adenosylhomocysteine hydrolase inhibitors against human cytomegalovirus replication.
1993 Jul
Anti-human immunodeficiency virus 1 (HIV-1) activities of 3-deazaadenosine analogs: increased potency against 3'-azido-3'-deoxythymidine-resistant HIV-1 strains.
1995 Jan 3
S-adenosylhomocysteine hydrolase inhibitors interfere with the replication of human immunodeficiency virus type 1 through inhibition of the LTR transactivation.
1997 Dec
Carbocyclic adenosine analogues as S-adenosylhomocysteine hydrolase inhibitors and antiviral agents: recent advances.
1998 Jan-Mar
Carboxy terminal variants of Epstein-Barr virus-encoded latent membrane protein 1 during long-term human immunodeficiency virus infection: reliable markers for individual strain identification.
1999 Jan
Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-L-homocysteine hydrolase inhibitor.
2000 Feb
Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections.
2001 Apr
3-deazaneplanocin A induces massively increased interferon-alpha production in Ebola virus-infected mice.
2002 Jul
Identification of active antiviral compounds against a New York isolate of West Nile virus.
2002 Jul
Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections.
2003 Jan
Anti-HIV-1 activity of 3-deaza-adenosine analogs. Inhibition of S-adenosylhomocysteine hydrolase and nucleotide congeners.
2003 Sep
Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and beta-D-N4-hydroxycytidine.
2004 Jan
Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity.
2013 Dec
Epigenetic silencing of microRNA-218 via EZH2-mediated H3K27 trimethylation is involved in malignant transformation of HBE cells induced by cigarette smoke extract.
2016 Feb
Substance Class Chemical
Created
by admin
on Sat Dec 16 08:39:58 GMT 2023
Edited
by admin
on Sat Dec 16 08:39:58 GMT 2023
Record UNII
544SH4020S
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
3-DEAZANEPLANOCIN
Common Name English
(1S,2R,5R)-5-(4-AMINOIMIDAZO(4,5-C)PYRIDIN-1-YL)-3-(HYDROXYMETHYL)CYCLOPENT-3-ENE-1,2-DIOL
Systematic Name English
Code System Code Type Description
FDA UNII
544SH4020S
Created by admin on Sat Dec 16 08:39:58 GMT 2023 , Edited by admin on Sat Dec 16 08:39:58 GMT 2023
PRIMARY
CAS
102052-95-9
Created by admin on Sat Dec 16 08:39:58 GMT 2023 , Edited by admin on Sat Dec 16 08:39:58 GMT 2023
PRIMARY
WIKIPEDIA
3-Deazaneplanocin A
Created by admin on Sat Dec 16 08:39:58 GMT 2023 , Edited by admin on Sat Dec 16 08:39:58 GMT 2023
PRIMARY
EPA CompTox
DTXSID30144562
Created by admin on Sat Dec 16 08:39:58 GMT 2023 , Edited by admin on Sat Dec 16 08:39:58 GMT 2023
PRIMARY
PUBCHEM
73087
Created by admin on Sat Dec 16 08:39:58 GMT 2023 , Edited by admin on Sat Dec 16 08:39:58 GMT 2023
PRIMARY